Knox Lane acquires Cross Country Healthcare
Knox Lane has signed an agreement to acquire Cross Country Healthcare for $437 million, marking a significant transaction in the healthcare sector. This all-cash deal, valuing Cross Country Healthcare at a 31% premium over its recent closing price, is set to transition the publicly traded company to a privately-held entity under Knox Lane's portfolio. The acquisition underscores the investment firm’s ambition to enhance growth within the healthcare workforce solutions market.
The terms of the agreement stipulate that Knox Lane will purchase all outstanding shares of Cross Country Healthcare common stock. Cross Country’s stockholders are expected to vote on this as one of the customary closing conditions, alongside necessary regulatory approvals. The deal is anticipated to close by the third quarter of 2026. Post-acquisition, Cross Country Healthcare will delist from the Nasdaq and continue operations under its current name.
Cross Country Healthcare, known for its technology-driven solutions within healthcare workforce management, views the acquisition as a pathway to accelerate its platform's evolution. Underpinned by four decades of industry experience and bolstered by its AI-powered Intellify platform, Cross Country aims to advance its labor strategies and client service offerings. The company’s CEO, Kevin, expressed confidence in Knox Lane’s sector expertise and the strategic alignment that the investment firm brings to foster continued innovation and growth.
For Knox Lane, the acquisition represents an opportunity to leverage its expertise in scaling technology platforms and optimize operational efficiencies within the healthcare staffing domain. As articulated by Knox Lane’s leadership, the firm is poised to enhance Cross Country’s technology infrastructure and expand its service capabilities, aiming to solidify its position as a premier partner in healthcare staffing solutions.
As the transaction progresses towards finalization, it remains subject to various approvals and customary closing conditions. The outcome will be closely watched by market participants evaluating the implications for competition in the healthcare staffing sector. Moreover, strategic moves such as this underscore the ongoing trend of private equity interests deepening their footprint in healthcare services, targeting firms with robust technology-driven business models poised for scalability.
Deal timeline
This transaction is classified in Healthcare with a reported deal value of $437M. Figures and status may change as sources update.